Form 4: Eli Lilly Executive Ilya Yuffa Reports RSU Vesting

Eli Lilly & Co. executive Ilya Yuffa reported the vesting of restricted stock units and subsequent tax-related share disposition.

Summary

• Ilya Yuffa, EVP & President, LLY USA & Global Capabilities at Eli Lilly & Co. (LLY), reported transactions involving the company's common stock.
• On February 1, 2026, Yuffa acquired 3,394 shares of common stock through the vesting of restricted stock units (RSUs).
• Concurrently, 1,512.364 shares were disposed of at a price of $1,037.15 per share to cover tax liabilities associated with the RSU vesting.
• Following these transactions, Yuffa directly beneficially owns 28,141.607 shares of Eli Lilly & Co. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, reflecting routine executive compensation activities rather than a strategic move or a significant change in company prospects.

Positives

• The vesting of 3,394 restricted stock units indicates the fulfillment of long-term incentive compensation for a key executive.
• The acquisition of shares through vesting increases the executive's direct ownership in the company, aligning interests with shareholders.

Negatives

• A portion of the vested shares (1,512.364 shares) was disposed of to cover tax obligations, which is a routine event but represents a reduction in the total shares acquired.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transactions like RSU vesting and tax-related sales are common across the pharmaceutical industry as part of executive compensation structures and typically do not signal significant shifts in company strategy or performance.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine executive compensation event.
• Reinforces executive alignment with shareholder interests through continued stock ownership.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event involving the vesting of restricted stock units and subsequent tax-related share disposition. It does not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals and market conditions.

Keywords

Eli Lilly, LLY, Ilya Yuffa, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership